TerminatedNCT03423667
Efficacy of N-acetylcysteine on the Craving Symptoms of Abstinent Hospitalized Patients With Cocaine Addiction
Medication studyAges 18–80Belgium
Understand this study
Who could participate?
Listed age limits: 18 years to 80 years.
- Listed locations
- BrusselsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: March 1, 2019
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 33
- Sponsor
- Salvatore Campanella
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Belgium
- Age range
- From 18 Years to 80 Years
- Official registry ID
- NCT03423667
- Official title
Show the full official title
Efficacy of N-acetylcysteine on the Craving Symptoms of Abstinent Hospitalized Patients With Cocaine Addiction
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Brussels
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Salvatore Campanella.
Does this study involve medication?
Yes. The study involves medication, including N-acetylcysteine and Lactose powder.
Who can participate?
Listed age limits: 18 years to 80 years.
Is this study still recruiting?
The registry lists this study as terminated.
